FDA Approves Tests from Siemens, Becton Dickinson, and Roche in FebruaryMarch 15th, 2018
Roche Diagnostics Named One of the 2018 “Top 70 Companies for Executive Women”March 14th, 2018
AACC Annual Scientific Meeting and Clinical Lab Expo
ChicagoBooth No.: 3849
Medlab - The World’s Largest Expo
DubaiBooth No.: Z5 G 42
MEDICA 2017 - World Forum for Medicine
Düsseldorf, GermanyBooth No.: 3/D35-2
69th AACC Annual Meeting and Clinical Lab Expo - July 30 - August 3, 2017
SAN DIEGO, CA, USA
Thanks to Block Scientific, I was able to procure the re-certified Bayer DCA 2000+ without hassles and get the lab back in operation. The
device works perfectly and I look forward to doing more business with Block Scientific.
--- Mathew Anderson, New Jersey
LDL-Cholesterol test kit (liquid stable), R1: 4 x 60 ml R2: 4 x 20 ml
The Diazyme LDL-Cholesterol assay is a direct dual liquid stable reagent system which can be used reliably with fasting and non-fasting specimens. Reagent transfer is eliminated for most chemistry systems with a choice of convenient instrument specific packaging options including Roche Hitachi 917 series, Olympus AU (400/600/640/680), Beckman Synchron CX, LX and DXC. The assay utilizes Diazyme’s proprietary PVS\PEGME coupled technology which provides outstanding performance. The assay features a linear range of up to 250 mg/dL, intra and inter %CV values < 5.0 % and less than 10% interference from triglycerides to 1000 mg/dL, ascorbic acid to 10 mmol/L, bilirubin to 40 mg/dL, bilirubin conjugate to 30 mg/dL, hemoglobin to 1000 mg/dL. The reagent is stable for 15 months from date of certification when stored @ 2°- 8°C.
The Diazyme LDL-Cholesterol Assay is intended for the in vitro quantitative determination of Low Density Lipoprotein Cholesterol in human serum or plasma. The reagents can assist in the diagnosis and treatment of patients at risk of developing coronary heart disease. Elevated LDL cholesterol is the primary target of cholesterol-lowering therapy.